Elequin Capital’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

Elequin Capital’s Portfolio THAC Stock Details THAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$5.15K	–	690
2022 Q4	$5.15K	Hold	500	–	–	﹤0.01%	510
2022 Q3	$5K	Buy	+500	New	+$5.05K	﹤0.01%	398

Elequin Capital's THAC Position: Q1 2023 in Review

Elequin Capital sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 500 shares — an estimated $5.15K sold.

Elequin Capital first reported a position in THAC in Q3 2022 and held it in 2 quarters. The position peaked at $5.15K in Q4 2022. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

Elequin Capital reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
Elequin Capital sold 500 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $5.15K.
Elequin Capital first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q3 2022 and held it in 2 quarters.
Elequin Capital's Thrive Acquisition Corporation Class A ordinary shares position peaked at $5.15K in Q4 2022.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on Elequin Capital's 13F filing for Q1 2023, filed 11 May 2023.